Spatiotemporally Skewed Activation of Programmed Cell Death Receptor 1-Positive T Cells after Epstein-Barr Virus Infection and Tumor Development in Long-Term Fully Humanized Mice.
Animals
CD4-Positive T-Lymphocytes
/ immunology
CD8-Positive T-Lymphocytes
/ immunology
Epstein-Barr Virus Infections
/ immunology
Herpesvirus 4, Human
/ immunology
Humans
Lymphocyte Activation
Mice
Mice, Mutant Strains
Neoplasm Proteins
/ immunology
Neoplasms
/ immunology
Programmed Cell Death 1 Receptor
/ immunology
Journal
The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
04
06
2018
revised:
26
10
2018
accepted:
06
11
2018
pubmed:
30
12
2018
medline:
13
11
2019
entrez:
30
12
2018
Statut:
ppublish
Résumé
Humanized mice developing functional human T cells endogenously and capable of recognizing cognate human leukocyte antigen-matched tumors are emerging as relevant models for studying human immuno-oncology in vivo. Herein, mice transplanted with human CD34
Identifiants
pubmed: 30593822
pii: S0002-9440(18)30470-X
doi: 10.1016/j.ajpath.2018.11.014
pmc: PMC6902117
pii:
doi:
Substances chimiques
Neoplasm Proteins
0
PDCD1 protein, human
0
Programmed Cell Death 1 Receptor
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
521-539Informations de copyright
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Références
Biol Blood Marrow Transplant. 2013 Oct;19(10):1480-92
pubmed: 23891747
Front Immunol. 2017 Dec 08;8:1709
pubmed: 29276513
Mol Biotechnol. 2009 May;42(1):110-6
pubmed: 19160076
J Immunol. 2011 May 15;186(10):5854-62
pubmed: 21460204
J Virol. 2015 May;89(10):5222-37
pubmed: 25787276
J Virol. 2011 Jan;85(1):165-77
pubmed: 20980506
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50
pubmed: 9653172
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Clin Exp Immunol. 2008 Nov;154(2):270-84
pubmed: 18785974
Eur J Immunol. 2017 Jun;47(6):946-953
pubmed: 28475283
J Exp Med. 2009 Jun 8;206(6):1423-34
pubmed: 19487422
PLoS Pathog. 2016 May 17;12(5):e1005642
pubmed: 27186886
Science. 2004 Apr 2;304(5667):104-7
pubmed: 15064419
J Virol. 2004 Dec;78(24):13891-900
pubmed: 15564497
Am J Pathol. 2017 Jun;187(6):1380-1398
pubmed: 28432872
J Immunol. 2014 May 15;192(10):4636-47
pubmed: 24740501
Immunobiology. 2014 Feb;219(2):131-7
pubmed: 24094417
Annu Rev Pathol. 2017 Jan 24;12:187-215
pubmed: 27959627
Am J Transplant. 2008 Feb;8(2):442-5
pubmed: 18211510
Gene. 1996 Feb 22;169(1):47-52
pubmed: 8635748
J Immunol. 2013 Mar 1;190(5):2090-101
pubmed: 23335750
Nucleic Acids Res. 2005 Feb 24;33(4):e36
pubmed: 15731329
J Virol. 2012 Aug;86(15):7976-87
pubmed: 22623780
N Engl J Med. 2017 Dec 21;377(25):2500-2501
pubmed: 29262275
Nat Med. 2006 Nov;12(11):1316-22
pubmed: 17057712
Nature. 1984 Jul 19-25;310(5974):207-11
pubmed: 6087149
Exp Mol Med. 2015 Jan 23;47:e135
pubmed: 25613732
Annu Rev Pathol. 2006;1:375-404
pubmed: 18039120
J Infect Dis. 2009 Nov 15;200(10):1611-5
pubmed: 19832115
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13022-7
pubmed: 20615947
BMC Immunol. 2017 May 30;18(1):28
pubmed: 28558649
Cell. 2016 Sep 8;166(6):1500-1511.e9
pubmed: 27610572
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
J Virol. 2015 Jul;89(14):7248-61
pubmed: 25948739
FASEB J. 2018 Mar;32(3):1537-1549
pubmed: 29146734
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13081-6
pubmed: 26438862